Oragenics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.About OGEN
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains.
CEOJanet Huffman
CEOJanet Huffman
Employees3
Employees3
HeadquartersSarasota, Florida
HeadquartersSarasota, Florida
Founded1996
Founded1996
Employees3
Employees3
OGEN Key Statistics
Market cap3.91M
Market cap3.91M
Price-Earnings ratio-0.06
Price-Earnings ratio-0.06
Dividend yield—
Dividend yield—
Average volume37.80K
Average volume37.80K
High today$0.9372
High today$0.9372
Low today$0.8903
Low today$0.8903
Open price$0.9198
Open price$0.9198
Volume20.83K
Volume20.83K
52 Week high$18.90
52 Week high$18.90
52 Week low$0.735
52 Week low$0.735
Stock Snapshot
The current Oragenics(OGEN) stock price is $0.93, with a market capitalization of 3.91M. The stock trades at a price-to-earnings (P/E) ratio of -0.06.
On 2026-01-15, Oragenics(OGEN) stock traded between a low of $0.89 and a high of $0.94. Shares are currently priced at $0.93, which is +4.5% above the low and -0.8% below the high.
Oragenics(OGEN) shares are trading with a volume of 20.83K, against a daily average of 37.8K.
During the past year, Oragenics(OGEN) stock moved between $0.74 at its lowest and $18.90 at its peak.
During the past year, Oragenics(OGEN) stock moved between $0.74 at its lowest and $18.90 at its peak.
People also own
Based on the portfolios of people who own OGEN. This list is generated using Robinhood data, and it’s not a recommendation.